D
Denali Therapeutics Inc.
DNLI · NASDAQ · Healthcare · 3.9B
Price · close
$24.92
-0.12% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.3×
Enterprise value / EBITDAEV/EBITDA
-8.4×
Free cash flow yieldFCF yield
-9.7%
Return on equityROE
-50.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.